Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
NCT ID: NCT02684344
Last Updated: 2019-01-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
5 participants
INTERVENTIONAL
2016-02-29
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial
NCT06262048
The Effect of Tamsulosin on Postoperative Urinary Retention
NCT04682366
Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders
NCT04232683
Prevention of Post-operative Urinary Retention
NCT02486653
Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
NCT06843538
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tamsulosin Group
Subjects will receive:
1. 0.4mg tamsulosin by mouth nightly for 3 doses prior to the day of surgery and for 2 doses following surgery
2. education about signs and symptoms of urinary retention
Tamsulosin
Tamsulosin may have prophylactic properties against post-operative urinary retention
Education
Education about signs and symptoms of urinary retention
Education Group
Subjects will receive:
1\) education about signs and symptoms of urinary retention
Education
Education about signs and symptoms of urinary retention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tamsulosin
Tamsulosin may have prophylactic properties against post-operative urinary retention
Education
Education about signs and symptoms of urinary retention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled to undergo one of the planned surgeries (thoracic, general, or urologic)
* Ability to give informed consent
Exclusion Criteria
* Current use of a strong CYP 3A4 inhibitors
* Any allergy to tamsulosin, alpha-blocker medication class, or anaphylaxis allergy to sulfate containing medications
* Patients with any upcoming surgery for cataracts
* Currently enrolled in a clinical trial
* Inability to give informed consent
40 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Edward Messing
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edward E. Messing, MD
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
59730
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.